Introduction:
The market for generic pantoprazole, also known as Protonix, in Israel is experiencing significant growth due to the increasing prevalence of gastrointestinal disorders. According to recent data, the pharmaceutical industry in Israel is projected to reach a market size of $10 billion by 2025, with a focus on generic medications to reduce healthcare costs.
Top 10 Pantoprazole (Protonix) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceuticals is the leading manufacturer of pantoprazole generics in Israel, with a production volume of over 500,000 units per year. The company holds a market share of 30% in the local market and exports its products to over 50 countries worldwide.
2. Perrigo Company plc
Perrigo is another major player in the Israeli pantoprazole generic market, producing over 300,000 units annually. The company has a strong presence in the domestic market and is known for its high-quality products.
3. Taro Pharmaceutical Industries Ltd.
Taro Pharmaceuticals is a key player in the Israeli pharmaceutical industry, with a production volume of 200,000 units of pantoprazole generics per year. The company has a market share of 15% in Israel and exports its products to various countries in Europe and Asia.
4. Mylan N.V.
Mylan is a global pharmaceutical company with a significant presence in the Israeli market for pantoprazole generics. The company produces over 150,000 units annually and has a market share of 10% in Israel.
5. Sandoz International GmbH
Sandoz is a subsidiary of Novartis and is one of the top manufacturers of pantoprazole generics in Israel. The company produces over 100,000 units per year and has a market share of 8% in the local market.
6. Rafa Laboratories Ltd.
Rafa Laboratories is a leading Israeli pharmaceutical company that produces over 80,000 units of pantoprazole generics annually. The company has a strong presence in the domestic market and is known for its innovative products.
7. Unipharm Ltd.
Unipharm is a major player in the Israeli pharmaceutical industry, with a production volume of 70,000 units of pantoprazole generics per year. The company has a market share of 5% in Israel and exports its products to several countries in the Middle East.
8. Neopharm Group
Neopharm Group is a prominent Israeli pharmaceutical company that produces over 50,000 units of pantoprazole generics annually. The company has a market share of 4% in Israel and is known for its high-quality products.
9. Biopharm
Biopharm is a leading manufacturer of pantoprazole generics in Israel, producing over 40,000 units per year. The company has a market share of 3% in the local market and exports its products to several countries in Europe.
10. Dexcel Pharma
Dexcel Pharma is a key player in the Israeli pharmaceutical industry, with a production volume of 30,000 units of pantoprazole generics per year. The company has a market share of 2% in Israel and is known for its competitive pricing.
Insights:
The market for pantoprazole generics in Israel is expected to continue growing in the coming years, driven by the increasing prevalence of gastrointestinal disorders and the rising demand for affordable medications. According to industry projections, the market is expected to reach a value of $50 million by 2023, with a CAGR of 5%. To stay competitive, manufacturers will need to focus on innovation, quality, and cost-effectiveness to meet the evolving needs of patients and healthcare providers.
Related Analysis: View Previous Industry Report
